Abstract:e23270 Background: More and more attention has been paid to molecular subtype of cancers, for example the detection of ALK rearrangements in the diagnosis and treatment of lung cancers and lymphomas. FISH and IHC are two routine methods to detect ALK rearrangements or hybrids. However, some difficulties such as biopsy samples, costs, and waiting time for results may negatively affect the application of these methods. Therefore, there is a need to explore a novel, cheap and rapid method to be a good complement in the field of ALK rearrangements detection. Methods: Microarray data analysis and real-time PCR studies had been used for this study. Results: We identified an EST (Expressed Sequence Tags) from Affymetrix microarray studies, and the correlation coefficiency between signal intensity of probesets corresponding to EST and ALK in 1037 cancer cells (Cancer Cell Line Encyclopedia) reached 0.92. By compare the EST transcript expression levels, it was capable to accurately discriminate 8 ALK rearrangements positive lymphomas or lung tumor samples from other 112 ALK rearrangements negative lymphomas or lung tumors. Moreover, the expression of EST added synergetic effect to a known method when measure ALK rearrangement status by compare ALK transcript 5’ and 3’ portion expression. Samples’ ALK rearrangement status had been confirmed by FISH and/or IHC methods. Selected ALK hybrid subtypes had been screened by multiplex PCR, and confirmed by sequencing and Amoyx PCR methods. Conclusions: A homebrew PCR assay has been proposed, by evaluate ALK rearrangement status from three aspects: ① Characterize the EST gene expression; ② Compare the 5’ portion and 3’ portion of ALK transcript; ③ Check detailed known ALK hybrid subtype variants. A significant advantage of such homebrew PCR assay is that it could be readily applied to specimens such as Fine Needle Aspiration, Plural Fluid, Cerebro-Spinal Fluid that may not be suitable for preparation of FFPE samples, serve as a good complementary to FISH and IHC methodologies. Moreover, such prototype assay is transferable to the FilmArray platform, which is a FDA-cleared multiplex PCR system that integrates sample preparation, amplification, detection and analysis.

Clinical evaluation of the effectiveness of fusion-induced asymmetric transcription assay-based reverse transcription droplet digitalPCRfor<i>ALK</i>detection in formalin-fixed paraffin-embedded samples from lung cancer

Clinical evaluation of the effectiveness of fusion‐induced asymmetric transcription assay‐based reverse transcription droplet digital <scp>PCR</scp> for <scp> <i>ALK</i> </scp> detection in formalin‐fixed paraffin‐embedded samples from lung cancer

Accurate and Economical Detection of ALK Positive Lung Adenocarcinoma with Semiquantitative Immunohistochemical Screening

Detecting ALK Rearrangement with RT-PCR: A Reliable Approach Compared with Next-Generation Sequencing in Patients with NSCLC

Evaluation Of Alk Rearrangement In Chinese Non-Small Cell Lung Cancer Using Fish, Immunohistochemistry, And Real-Time Quantitative Rt- Pcr On Paraffin-Embedded Tissues

Development of a novel ALK rearrangement screening test for non-small cell lung cancers

The Use of Quantitative Real-Time Reverse Transcriptase PCR for 5′ and 3′ Portions of ALK Transcripts to Detect ALK Rearrangements in Lung Cancers

Exploration of ALK fused gene expression in non-small cell lung cancer patients by immuno-histochemistry

Alk-Rearranged Lung Cancer In Chinese: A Comprehensive Assessment Of Clinicopathology, Ihc, Fish And Rt-Pcr

Concordance of Immunohistochemistry and Fluorescent in Situ Hybridization for Anaplastic Lymphoma Kinase (alk) Rearrangement in Non-Small Cell Lung Cancer: Results from A Multicenter Study in China

The Research of Clinical Pathological Features of ALK Positive Lung Cancer in 525 Patients and the Discussion of Detection Methods

The Molecular Detection and Clinical Significance of ALK Rearrangement in Selected Advanced Non-Small Cell Lung Cancer: ALK Expression Provides Insights into ALK Targeted Therapy.

A Survival Comparison Study of Chinese Patients with Primary Lung Adenocarcinoma Harboring ALK Rearrangements with Crizotinib Treatment Detected by FISH, IHC, and RT-PCR.

[ALK protein expression and gene fusion in bronchoscopic specimens of lung adenocarcinoma].

Cell block samples from malignant pleural effusion might be valid alternative samples for anaplastic lymphoma kinase detection in patients with advanced non-small-cell lung cancer.

[ALK gene fusion associated non-small cell lung cancer: automated immunostainer detection and clinicopathologic perspectives]

Detection of EML4-ALK in Lung Adenocarcinoma Using Pleural Effusion with FISH, IHC, and RT-PCR Methods

Comparison of ALK Status Between Primary and Corresponding Lymph Node Metastatic Tumors in Lung Cancer Patients

Clinical Characteristics and Outcomes of Patients with Primary Lung Adenocarcinoma Harboring Alk Rearrangements Detected by Fish, Ihc, and Rt-Pcr

Anaplastic lymphoma kinase fusion gene expression, clinical pathological characteristics and prognosis in 95 Chinese patients with non-small cell lung cancer]

A Novel Homebrew Real-Time PCR Assay to Detect ALK Rearrangements in Lung Cancers and Lymphomas.